Overview

Study of Efficacy and Safety of MEXIDOL®

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A multicenter, prospective, randomized, double-blind, placebo-controlled, parallel group study in patients with stroke
Phase:
Phase 3
Details
Lead Sponsor:
Pharmasoft
Treatments:
Emoxypine succinate
Mexidol